NCT04073407View on ClinicalTrials.gov

Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)

NATerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 27, 2019

Primary Completion Date

April 15, 2020

Study Completion Date

September 1, 2020

Conditions
NAFLD
Interventions
DIETARY_SUPPLEMENT

AXA1957

Amino acids, food study

DIETARY_SUPPLEMENT

Placebo

placebo

Trial Locations (4)

E1 1BB

Royal London Children's Hospital, London

Unknown

King's College Hospital, London

Royal Manchester Children's Hospital, Manchester

S016 6YD

Univeristy of Southhampton, Southampton

Sponsors
All Listed Sponsors
lead

Axcella Health, Inc

INDUSTRY

NCT04073407 - Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) | Biotech Hunter | Biotech Hunter